Location History:
- Osaka, JP (1992)
- Hirakata, JP (1995)
- Tachikawa, JP (2009 - 2010)
- Fussa, JP (2008 - 2016)
- Tokyo, JP (2005 - 2019)
Company Filing History:
4 out of 33,464 
2 out of 4,714 
2 out of 260 
Years Active: 1992-2019
Title: Innovations by Masanori Morita in Human Prourokinase
Introduction
Masanori Morita, an accomplished inventor based in Osaka, Japan, has made significant contributions to the field of biotechnology. With a total of two patents registered under his name, Morita's work primarily focuses on improving the therapeutic applications of human prourokinase, an important enzyme in the fibrinolytic system.
Latest Patents
Masanori Morita's latest patents include innovative approaches to mutant human prourokinase. The first patent details a mutant human prourokinase wherein a neutral amino acid in the epidermal growth factor (EGF) region is exchanged with either a basic or a non-acidic amino acid. This alteration aims to enhance the stability of the enzyme in the bloodstream, thus prolonging its half-life and improving its affinity for fibrin.
The second patent outlines the creation of a human prourokinase mutant, characterized by the deletion or alteration of portions of the epidermal growth factor domain. The modifications are designed to retain the enzyme's activity while extending its blood half-life beyond that of the naturally occurring variant. Specifically, it mentions the modification of regions such as the segment from asparagine to cysteine and others.
Career Highlights
Throughout his career, Masanori Morita has worked at The Green Cross Corporation, a firm renowned for its advancements in biopharmaceuticals. His expertise in enzymology and modifications of biochemical compounds has positioned him as a key innovator within the company. Morita's contributions have paved the way for potential new therapies in the treatment of various medical conditions involving clotting.
Collaborations
Masanori Morita has collaborated with other notable professionals in his field, including Toshizumi Tanabe and Yasuo Amatsuji. Together, they have focused on pioneering research to develop more effective therapeutic solutions based on the unique properties of human prourokinase.
Conclusion
Masanori Morita's innovative work on human prourokinase demonstrates the vital role of inventors in advancing scientific knowledge and developing new medical treatments. His patents not only reflect his dedication to research but also highlight the potential of biotechnology in improving patient care. As an inventor, Morita continues to inspire and contribute to the scientific community with his groundbreaking inventions in biopharmaceutical research.